MilliporeSigma Life Science Capabilities Seminar: Follow the Molecule: From the Lab Bench to Drug Manufacturing
Join Connect Labs as it hosts MilliporeSigma for an exciting seminar that traces the full journey of drug development—from early discovery to manufacturing—highlighting the cutting-edge tools, platforms, and expertise that support biotech innovation at every stage.
With a portfolio of over 300,000 products, MilliporeSigma empowers researchers through advanced solutions in organoid modeling, genome engineering, immunoassays, and analytical characterization. Now bolstered by the recent acquisition of HUB Organoids, our capabilities in patient-derived organoid (PDO) screening, custom assay development, and co-clinical testing have expanded significantly. Attendees will also gain insight into our industry-leading CRISPR genome editing tools and comprehensive immunoassay platforms such as MILLIPLEX®, SMC®, and ELISA assays—essential for biomarker discovery and validation.
This seminar will also spotlight how our Emerging Biotech Group supports start-ups and early-stage companies with technical guidance, the Advance Biotech Grant Program, and key insights on navigating the transition from GLP to GMP.
Featured Topics & Speakers:
Biology & Target Identification – M. Zulfiquer Hossain
Immunoassay Platforms, Target Validation & Biomarkers – Krishna Subedi
Advanced Analytics & Characterization – Hillel Brandes
Preclinical Development & Manufacturing – Naomi Baer
Whether you’re at the research bench or scaling for clinical trials, this seminar offers valuable perspectives and resources to help accelerate your pipeline.
Refreshments will be provided.
Let’s advance life and health with science—together.
Join virtually through: Microsoft Teams Need help?
Meeting ID: 229 272 226 704 3
Passcode: xu6g5ds9